A significant medical achievement was recorded at Sultan Qaboos University Hospital in the management of acute poisoning. A ...
QTX-2101 is an investigational, oral arsenic trioxide therapy that has not yet been approved by any regulatory authority. Its safety and efficacy are currently under evaluation. This press release ...
Charlottesville, Va, Jan. 21, 2026 (GLOBE NEWSWIRE) -- A scientific discovery aimed at stopping dangerous immune-system ...
This “long overdue” update expands the pools of patients eligible for thrombolysis and thrombectomy, and tackles pediatric ...
Pediatric acute myeloid leukemia (AML) is one of the most common acute leukemias in children. While treatment outcomes have ...
Among patients initially treated with antibiotics for uncomplicated acute appendicitis, the rate of recurrence and appendectomy at 10-year follow-up supports the use of antibiotics as an option for ...
AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...
Real-world data show how microbiological findings and patient factors can guide empirical antibiotic choice in acute ...
During the opioid crisis in the United States, acute pain management has remained a persistent challenge for both patients and clinicians.
How nutrition therapy supports recovery, rehabilitation, and quality of life in patients with chronic critical illness and ...
For pediatric nonoperative fractures and sprains, adding acetaminophen or hydromorphone to ibuprofen does not provide better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results